Evonik AI Stock Analysis
Want to see DE:EVK full AI Analyst Report?
Evonik (EVK) AI Stock Analysis
Evonik
(XETRA:EVK)
The score is primarily supported by steady cash generation and a generally sound balance sheet, along with constructive technical momentum above key moving averages. Offsetting these positives are weak profitability/returns and a very high P/E multiple, which together cap the overall score despite the solid dividend yield.
Evonik (EVK) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 9.68B
- Dividend Yield
- 4.77%
- Average Volume (3M)
- 1.33M
- Price to Earnings (P/E)
- 55.4
- Beta (1Y)
- 0.76
- Revenue Growth
- 1.98%
- EPS Growth
- 83.13%
- Country
- Germany
- Employees
- 30,356
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Evonik Business Overview & Revenue Model
Company Description
Evonik Industries AG operates primarily in the specialized chemicals market. Its business activities are structured across five principal divisions: Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infra...
How the Company Makes Money
Evonik makes money primarily by manufacturing and selling specialty chemical products and solutions to business customers (B2B). Its revenue model is largely volume- and price-driven sales of differentiated materials and formulation components that i...
Evonik Financial Statement Overview
Summary
Cash flow is the clear strength (solid operating cash flow and healthy free cash flow with positive growth), and leverage appears manageable. The main constraint is weak and volatile profitability: net margin is ~0.9% TTM with low ROE (~1.5%), and earnings/revenue have shown multi-year volatility (including a net loss in 2023).
Income Statement
56NeutralBalance Sheet
63PositiveCash Flow
71Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.55B | 14.07B | 15.16B | 15.27B | 18.49B | 14.96B |
| Gross Profit | 3.38B | 3.24B | 3.74B | 3.39B | 4.23B | 4.03B |
| EBITDA | 2.41B | 1.84B | 1.76B | 991.00M | 2.07B | 2.18B |
| Net Income | 174.00M | 265.00M | 222.00M | -465.00M | 540.00M | 746.00M |
Balance Sheet | ||||||
| Total Assets | 18.81B | 19.21B | 19.75B | 21.26B | 21.81B | 22.28B |
| Cash, Cash Equivalents and Short-Term Investments | 533.00M | 619.00M | 618.00M | 1.03B | 1.12B | 919.00M |
| Total Debt | 4.34B | 3.87B | 3.78B | 4.25B | 4.22B | 3.64B |
| Total Liabilities | 10.72B | 11.04B | 10.65B | 12.28B | 10.75B | 12.91B |
| Stockholders Equity | 8.03B | 8.11B | 9.02B | 8.91B | 10.97B | 9.29B |
Cash Flow | ||||||
| Free Cash Flow | 919.00M | 695.00M | 873.00M | 801.00M | 785.00M | 929.00M |
| Operating Cash Flow | 1.72B | 1.44B | 1.71B | 1.59B | 1.65B | 1.81B |
| Investing Cash Flow | -732.00M | -652.00M | -663.00M | -653.00M | -777.00M | -1.07B |
| Financing Cash Flow | -914.00M | -731.00M | -1.33B | -823.00M | -672.00M | -856.00M |
Evonik Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:EVK, the sentiment is Neutral. The current price of 20.96 is below the 20-day moving average (MA) of 21.12, above the 50-day MA of 19.94, and above the 200-day MA of 16.89, indicating a neutral trend. The MACD of 0.25 indicates Positive momentum. The RSI at 50.01 is Neutral, neither overbought nor oversold. The STOCH value of 40.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for DE:EVK.
Evonik Peers Comparison
Overall Rating
- DE:EVK62Neutral
DE:BNR62Neutral
DE:WCH54Neutral
DE:1COV50Neutral
DE:SY150Neutral
DE:LXS43Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| DE:EVK | 62Neutral | EUR 9.68B | 55.36 | 2.16% | 4.77% | 1.98% | 83.13% |
| DE:BNR | 62Neutral | EUR 8.89B | 23.58 | 8.30% | 3.20% | 0.32% | -8.91% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| DE:WCH | 54Neutral | EUR 3.99B | -15.25 | -6.82% | 3.11% | ― | ― |
| DE:1COV | 50Neutral | EUR 12.48B | -23.78 | -7.29% | ― | -8.72% | -140.66% |
| DE:SY1 | 50Neutral | EUR 13.13B | 35.84 | 9.90% | 1.31% | -1.45% | -50.97% |
| DE:LXS | 43Neutral | EUR 1.13B | -1.68 | -18.99% | 0.77% | -3.63% | -172.43% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:EVK | Evonik Industries AG | 20.96 | 7.70 | 58.07% | |
| DE:BNR | Brenntag AG (UK) | 59.42 | 11.21 | 23.25% | |
| DE:1COV | Covestro AG | 60.40 | 1.38 | 2.34% | |
| DE:SY1 | Symrise AG | 95.44 | 23.27 | 32.24% | |
| DE:LXS | Lanxess (OTC) | 12.92 | -4.95 | -27.68% | |
| DE:WCH | Wacker Chemie Ag (OTC) | 82.65 | 16.55 | 25.04% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 04, 2026